Volume 373, Issue 9677, Pages (May 2009)

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Volume 370, Issue 9600, Pages (November 2007)
Volume 370, Issue 9586, Pages (August 2007)
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.
Volume 380, Issue 9846, Pages (September 2012)
Volume 357, Issue 9273, Pages (June 2001)
Volume 364, Issue 9440, Pages (September 2004)
Volume 367, Issue 9517, Pages (April 2006)
Volume 2, Issue 5, Pages (May 2015)
Volume 357, Issue 9257, Pages (March 2001)
Pharmacogenetics and future drug development and delivery
Volume 349, Issue 9057, Pages (April 1997)
Volume 12, Issue 11, Pages (October 2011)
Volume 376, Issue 9747, Pages (October 2010)
Volume 11, Issue 4, Pages (April 2012)
Volume 15, Issue 6, Pages (May 2014)
Volume 376, Issue 9734, Pages (July 2010)
Volume 17, Issue 2, Pages (February 2016)
Long-term effects of hormone replacement therapy
Meta-analysis of randomised controlled trials
Volume 5, Issue 4, Pages (April 2006)
Volume 389, Issue 10076, Pages (April 2017)
Low-level laser therapy for neck pain
Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation.
Volume 371, Issue 9611, Pages (February 2008)
Volume 376, Issue 9734, Pages (July 2010)
Volume 390, Issue 10092, Pages (July 2017)
Volume 392, Issue 10145, Pages (August 2018)
Long-term effects of hormone replacement therapy
Volume 12, Issue 9, Pages (September 2013)
Aspirin in the prevention of cancer – Author's reply
Volume 14, Issue 12, Pages (December 2015)
Volume 14, Issue 10, Pages (September 2013)
Volume 9, Issue 9, Pages (September 2008)
Volume 356, Issue 9241, Pages (November 2000)
Volume 390, Issue 10092, Pages (July 2017)
Volume 9, Issue 10, Pages (October 2008)
Volume 12, Issue 7, Pages (July 2011)
Incident diabetes in clinical trials of antihypertensive drugs
Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised,
Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study  Sune F Nielsen, PhD, Prof Børge G Nordestgaard,
Volume 381, Issue 9875, Pages (April 2013)
Volume 379, Issue 9812, Pages (January 2012)
Volume 384, Issue 9944, Pages (August 2014)
Volume 15, Issue 1, Pages (January 2014)
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled.
Volume 9, Issue 9, Pages (September 2008)
Volume 375, Issue 9709, Pages (January 2010)
Volume 372, Issue 9647, Pages (October 2008)
Volume 371, Issue 9627, Pages (May 2008)
Volume 378, Issue 9786, Pages (July 2011)
Telling it like it isn't: truth and lies in a post-9/11 world
Volume 9, Issue 4, Pages (April 2008)
Volume 8, Issue 5, Pages (May 2009)
Volume 375, Issue 9726, Pages (May 2010)
Volume 373, Issue 9658, Pages (January 2009)
Volume 375, Issue 9719, Pages (March 2010)
Volume 375, Issue 9714, Pages (February 2010)
Volume 15, Issue 6, Pages (May 2014)
Volume 361, Issue 9352, Pages (January 2003)
Volume 11, Issue 3, Pages (March 2010)
Volume 381, Issue 9878, Pages (May 2013)
Volume 373, Issue 9672, Pages (April 2009)
Volume 371, Issue 9618, Pages (March 2008)
Volume 376, Issue 9747, Pages (October 2010)
Volume 12, Issue 1, Pages (January 2011)
Volume 20, Issue 5, Pages (May 2019)
Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,
Volume 371, Issue 9611, Pages (February 2008)
Volume 17, Issue 2, Pages (February 2016)
Presentation transcript:

Volume 373, Issue 9677, Pages 1780-1788 (May 2009) Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial  Dr Kushwin Rajamani, MBBCh, Prof Peter G Colman, MD, Li Ping Li, BMed, Prof James D Best, MD, Merryn Voysey, MBiostat, Michael C D'Emden, FRACP, Prof Markku Laakso, MD, John R Baker, MD, Prof Anthony C Keech, FRACP  The Lancet  Volume 373, Issue 9677, Pages 1780-1788 (May 2009) DOI: 10.1016/S0140-6736(09)60698-X Copyright © 2009 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile of amputation study ITT=intention to treat. *Three patients had non-traumatic amputation unrelated to diabetes. The Lancet 2009 373, 1780-1788DOI: (10.1016/S0140-6736(09)60698-X) Copyright © 2009 Elsevier Ltd Terms and Conditions

Figure 2 Effects of fenofibrate on first and all amputation events HR=hazard ratio. Counts for each category of amputation are shown. *Patients were counted only once within each category but may be included in more than one category if they had more than one type of amputation. If a patient had more than one type of amputation, or more than one of the same type of amputation, only the first event of each type was analysed. †For all events, all amputations for each category are counted (Poisson method): the incidence rate ratio, analogous to the hazard ratio, is plotted. The Lancet 2009 373, 1780-1788DOI: (10.1016/S0140-6736(09)60698-X) Copyright © 2009 Elsevier Ltd Terms and Conditions

Figure 3 Cumulative risk curves of time to first amputation (minor, major, any) event, by treatment group Patients could be counted in more than one category, but only once per category. The Lancet 2009 373, 1780-1788DOI: (10.1016/S0140-6736(09)60698-X) Copyright © 2009 Elsevier Ltd Terms and Conditions